"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...
A new report by the Federal Trade Commission says pharmacy benefit management companies are driving up your out-of-pocket costs for prescription drugs.
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
A new Federal Trade Commission (FTC) report found that the three largest Pharmacy Benefit Managers (PBMs ... Pharmaceutical Care Management Association Vice President of Public Affairs Greg ...
A new report from the Federal Trade Commission is uncovering what appears to be a major driver of the high cost of ...
The Federal Trade Commission suggests that PBMs profit from specialty generic drugs such as those for cancer and HIV and ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback